How many clinical trials are studying Hydroxychloroquine?

7 recruiting trials in our tracked data involve Hydroxychloroquine.

What conditions is Hydroxychloroquine being studied for?

In our tracked recruiting trials, Hydroxychloroquine is being studied in trials for Rheumatoid Arthritis, Lupus, Advanced Biliary Tract Carcinoma.

Hydroxychloroquine: clinical trials recruiting now

Q: Is Hydroxychloroquine FDA-approved?

Yes. According to the FDA drug label available through openFDA, Hydroxychloroquine is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA drug label

FDA-approved: Yes. Hydroxychloroquine appears in the FDA drug-label database. Marketed as Hydroxychloroquine.

FDA-approved use

Hydroxychloroquine sulfate is an antimalarial and antirheumatic indicated for the: Treatment of uncomplicated malaria due to Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, and Plasmodium vivax in adult and pediatric patients. ( 1.1 ) Prophylaxis of malaria in geographic areas where chloroquine resistance is not reported in adult and pediatric patients. ( 1.1 ) Treatment of rheumatoid arthritis in adults. ( 1.2 ) Treatment of systemic lupus erythematosus in adults. ( 1.3 ) Treatment of chronic discoid lupus erythematosus in adults. ( 1.4 ) Limitations of Use ( 1.1 ): Hydroxychloroquine sulfate is not recommended for the: Treatment of complicated malaria. Treatment of chloroquine or hydroxychloroquine-resistant strains of Plasmodium species. Treatment of malaria acquired in geographic areas where chloroquine resistance occurs or when the Plasmodium species has not been identified. Prophylaxis of malaria in geographic areas where chloroquine resistance occurs. Prevention of relapses of P. vivax or P. ovale because it is not active against the hypnozoite liver stage forms of these parasites. For radical cure of P. vivax and P. ovale infections, concomitant therapy with a…

FDA label via openFDA

Phase breakdown

Phase 2 3 Phase 3 3 Phase 4 1

Conditions being studied

Condition	Trials
Rheumatoid Arthritis · Hydroxychloroquine for Rheumatoid Arthritis	3
Lupus	2
Advanced Biliary Tract Carcinoma	1
Advanced Colorectal Carcinoma	1
Advanced Gastroesophageal Junction Adenocarcinoma	1
Advanced Lung Adenocarcinoma	1
Advanced Malignant Solid Neoplasm	1
Advanced Ovarian Carcinoma	1
Advanced Pancreatic Carcinoma	1
Advanced Urothelial Carcinoma	1
Arthritis, Rheumatoid	1
Breast Cancer	1
Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8	1
Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8	1
Colorectal cancer	1

Recruiting trials involving Hydroxychloroquine

ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
NCT04523857 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
NCT05733000 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
NCT05799378 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · 12 locations
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
The Clinical Efficacy of Immunomodulators in RA Patients
NCT05626348 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia
NCT05287321 · Phase: Phase 3 · Ages: 19 Years to 50 Years · Sex: Female · 1 location
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

Is Hydroxychloroquine FDA-approved?

Yes, marketed as Hydroxychloroquine.

How many recruiting trials involve Hydroxychloroquine?

7 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.